S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
AAPL   261.81 (-0.15%)
FB   194.47 (+2.56%)
MSFT   147.07 (+0.66%)
GOOGL   1,297.21 (-0.08%)
AMZN   1,778.00 (+0.36%)
CGC   19.25 (-5.17%)
NVDA   209.61 (+0.69%)
MU   46.90 (+1.38%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
TSLA   349.93 (+1.40%)
T   39.17 (-0.51%)
AMD   36.71 (+1.10%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
PRI   129.95 (+0.56%)
NFLX   292.01 (-0.74%)
BAC   33.09 (-0.27%)
GILD   64.32 (-0.50%)
DIS   138.58 (+1.35%)
S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
AAPL   261.81 (-0.15%)
FB   194.47 (+2.56%)
MSFT   147.07 (+0.66%)
GOOGL   1,297.21 (-0.08%)
AMZN   1,778.00 (+0.36%)
CGC   19.25 (-5.17%)
NVDA   209.61 (+0.69%)
MU   46.90 (+1.38%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
TSLA   349.93 (+1.40%)
T   39.17 (-0.51%)
AMD   36.71 (+1.10%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
PRI   129.95 (+0.56%)
NFLX   292.01 (-0.74%)
BAC   33.09 (-0.27%)
GILD   64.32 (-0.50%)
DIS   138.58 (+1.35%)
Log in

Glanbia Stock Price, Forecast & Analysis (LON:GLB)

GBX 11.49
-0.04 (-0.35 %)
(As of 11/12/2019 04:00 PM ET)
Today's Range
11.21
Now: GBX 11.49
11.57
50-Day Range
9.95
MA: GBX 359.84
1,143
52-Week Range
10.84
Now: GBX 11.49
1,938
Volume33,666 shs
Average Volume224,675 shs
Market Capitalization£34.02 million
P/E Ratio15.53
Dividend Yield2.51%
BetaN/A
Glanbia plc operates as a nutrition company worldwide. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, the Internet, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment operates as a milk processor in Ireland; and produces a range of value added dairy ingredients and consumer products. It also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, BSN, Isopure, Nutramino, ABB, thinkThin, Amazing Grass, Body & Fit, and SlimFast brands in approximately 100 countries. The company was founded in 1964 and is headquartered in Kilkenny, Ireland.

Industry, Sector and Symbol

Industry Food - Major Diversified
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+353-56-7772200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£2.67 billion
Cash FlowGBX 65.40 per share
Book ValueGBX 548.40 per share

Profitability

Miscellaneous

Employees6,900
Market Cap£34.02 million
Next Earnings DateN/A
OptionableNot Optionable

Receive GLB News and Ratings via Email

Sign-up to receive the latest news and ratings for GLB and its competitors with MarketBeat's FREE daily newsletter.


Glanbia (LON:GLB) Frequently Asked Questions

What is Glanbia's stock symbol?

Glanbia trades on the London Stock Exchange (LON) under the ticker symbol "GLB."

How often does Glanbia pay dividends? What is the dividend yield for Glanbia?

Glanbia announced a dividend on Wednesday, July 31st. Investors of record on Thursday, August 22nd will be given a dividend of GBX 0.11 per share on Friday, October 4th. This represents a yield of 0.9%. The ex-dividend date is Thursday, August 22nd. The official announcement can be seen at this link. View Glanbia's Dividend History.

What price target have analysts set for GLB?

1 brokerages have issued 12-month target prices for Glanbia's shares. Their forecasts range from GBX 1,680 to GBX 1,680. On average, they anticipate Glanbia's stock price to reach GBX 1,680 in the next twelve months. This suggests a possible upside of 14,521.4% from the stock's current price. View Analyst Price Targets for Glanbia.

What is the consensus analysts' recommendation for Glanbia?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Glanbia in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Glanbia.

Has Glanbia been receiving favorable news coverage?

Headlines about GLB stock have been trending very negative recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Glanbia earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Glanbia.

Who are some of Glanbia's key competitors?

What other stocks do shareholders of Glanbia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Glanbia investors own include Reckitt Benckiser Group (RB), KERRY GRP PLC/S (KRYAY), Glanbia (GLAPF), SYSCO (SYY), Ryanair (RYA), Primary Health Properties (PHP), Mears Group (MER), Kerry Group (KYGA), Atalaya Mining (ATYM) and Amryt Pharma (AMYT).

Who are Glanbia's key executives?

Glanbia's management team includes the folowing people:
  • Ms. Siobhán Talbot, Group MD & Exec. Director (Age 55)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 55)
  • Mr. Brian Phelan, Chief Exec. Officer of Glanbia Nutritionals (Age 52)
  • Mr. Hugh McGuire, Chief Exec. Officer of Glanbia Performance Nutrition (Age 48)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations

How do I buy shares of Glanbia?

Shares of GLB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Glanbia's stock price today?

One share of GLB stock can currently be purchased for approximately GBX 11.49.

How big of a company is Glanbia?

Glanbia has a market capitalization of £34.02 million and generates £2.67 billion in revenue each year. Glanbia employs 6,900 workers across the globe.View Additional Information About Glanbia.

What is Glanbia's official website?

The official website for Glanbia is http://www.glanbia.com/.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House, KILKENNY,, Ireland. The company can be reached via phone at +353-56-7772200.


MarketBeat Community Rating for Glanbia (LON GLB)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  155
MarketBeat's community ratings are surveys of what our community members think about Glanbia and other stocks. Vote "Outperform" if you believe GLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel